OptimizeRx
OPRX
110 hedge funds and large institutions have $168M invested in OptimizeRx in 2025 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 32 increasing their positions, 25 reducing their positions, and 7 closing their positions.
343% more first-time investments, than exits
New positions opened: 31 | Existing positions closed: 7
147% more call options, than puts
Call options by funds: $3.09M | Put options by funds: $1.25M
65% more capital invested
Capital invested by funds: $102M → $168M (+$66.6M)
28% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 25
26% more funds holding
Funds holding: 87 → 110 (+23)
3.89% more ownership
Funds ownership: 63.47% → 67.35% (+3.9%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MHP
Manatuck Hill Partners
Westport,
Connecticut
|
+$2.9M |
| 2 |
Balyasny Asset Management
Chicago,
Illinois
|
+$1.71M |
| 3 |
SSA
Schonfeld Strategic Advisors
New York
|
+$1.33M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$1.21M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$990K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
-$2.54M |
| 2 |
RA
Royce & Associates
New York
|
-$2.23M |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$1.52M |
| 4 |
BlackRock
New York
|
-$1.09M |
| 5 |
Janney Montgomery Scott
Philadelphia,
Pennsylvania
|
-$1.08M |
OPRX Hedge Fund Activity: Q2 2025 in Review
110 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in OptimizeRx (OPRX) for Q2 2025, worth a combined $168M — up 65% from $102M a quarter earlier.
Buyers outnumbered sellers: 31 funds opened new OPRX positions and 7 closed out — a net gain of 24 holders — while 32 added to existing stakes and 25 trimmed.
The largest buyer was Manatuck Hill Partners, adding an estimated $2.9M. The largest seller was Invesco, exiting entirely with an estimated $2.54M sold.
- 110 institutional investors held OptimizeRx (OPRX) as of Q2 2025, up from 87 in Q1 2025.
- Funds reported $168M of OptimizeRx stock for Q2 2025, up 65% quarter-over-quarter.
- 31 funds opened new OptimizeRx positions in Q2 2025 and 7 closed out, a net change of +24 holders.
- The largest OptimizeRx buyer in Q2 2025 was Manatuck Hill Partners, an estimated $2.9M added.
- The largest OptimizeRx seller in Q2 2025 was Invesco, an estimated $2.54M sold.
Based on aggregated 13F filings for Q2 2025.